All filters
Slidesets
A Next Generation HBV Capsid Inhibitor, AB-506: In Vitro and In Vivo Antiviral Characterization- Dr. N. Mani
Presented at:
HEP DART 2017
Slidesets
NASH Globally: Pathways to Combination Therapy, Biomarkers and Outcomes- Arun Sanyal
Presented at:
HEP DART 2017
Slidesets
Predicting Susceptibility and Resistance for Hepatitis B Virus Capsid Assembly Effectors- Dr. B. Cox
Presented at:
HEP DART 2017
Slidesets
Evolving Role of Real-World Evidence in NASH and HCC: From Bench to Poolside (not available)- Michael Fried
Presented at:
HEP DART 2017
Slidesets
The Re-vival of Bile Acid Based Therapeutics for Children and Adults- Saul Karpen
Presented at:
HEP DART 2017
Slidesets
Update on Prophylactic HCV Vaccine Development- Andrea Cox, MD
Presented at:
HEP DART 2017
Slidesets
Hepatitis B virus splice variants are associated with and predictive of Liver cancer- Dr. P. Revill
Presented at:
HEP DART 2017
Slidesets
Seroclearance of HBsAg in Chronic Hepatitis B Virus Patients on Lamivudine, Tenofovir or Entecavir Therapy: A 10 Year Experience- Dr. S. Ono
Presented at:
HEP DART 2017
Slidesets
Lessons learned towards a Vaccine and Functional Cure for HIV (not available)- Mario Stevenson
Presented at:
HEP DART 2017
Slidesets
Liver Directed Acetyl-CoA Carboxylase Inhibitor GS-0976 For NASH (not available)- Adrian Ray
Presented at:
HEP DART 2017
Slidesets
The Effectiveness of Treatment for Chronic Hepatitis C (and Hepatitis B) in Pediatric Populations- Manal El-Sayed, MD, PhD
Presented at:
HEP DART 2017
Slidesets
Aramchol for NASH and beyond: From scientific rationale to clinical development- Carol Brosgart
Presented at:
HEP DART 2017
Slidesets
Hepatitis E in HIV- Kenneth Sherman, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
News on hepatitis delta and HIV infections- Vincent Soriano, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of HCV in intravenous drug users: special considerations- Rui Sarmento e Castro, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
EASL highlights 2017- Jürgen Rockstroh, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Management of end-stage liver disease in HIV patients- Ana Morbey, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
New insights in management of HIV/HBV co-infected patients- Juan Berenguer, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
HBV cure: what is coming in 5 – 10 years?- Patrick Kennedy, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Debate case based: Do we need resistance testing in HCV therapy to guide decision making? Pro stance- Francesca Ceccherini– Silberstein, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Special considerations before / during / after DAA therapy- Kosh Agarwal, MD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017
Slidesets
Virologist's perspective - Charles Boucher, MD, PhD
Presented at:
International Workshop on HIV & Hepatitis Co-infection 2017